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Abstract 
 
Incidental findings are common in medical imaging. There is a particularly 
high prevalence of incidental findings within the thorax, the most frequent 
being pulmonary nodules. Whilst pulmonary nodules have the potential to be 
malignant, the vast majority will be benign, resulting in a high number of false-
positive findings.  Low-resolution CT images produced during attenuation 
correction (AC) during single-photon emission tomography (SPECT) are 
essentially a by-product of the process. The high number of false-positive 
incidental findings detected on CTAC images causes a reporting dilemma. 
Early detection of cancer can be beneficial but false-positive findings and over 
diagnosis can be detrimental to the patient. CTAC images are not diagnostic 
quality and further diagnostic tests are usually necessary for definitive 
diagnosis to be reached.   Given the high number of false-positive findings, 
the psychological effects and harms to the patient should be given 
consideration.  This review recommends that caution should be taken when 
routine reporting of CTAC images occurs.  
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Introduction  
 
Medical imaging employs a range of modalities that yield both anatomical and 
functional information (1). Visual correlation of images from separate imaging 
modalities can provide more information than images from a single modality 
alone, though there is an inevitable risk of mis-registration between images 
that have been acquired during different imaging sessions. The development 
of hybrid imaging has led to the integration of two modalities in one machine, 
allowing co-registration of images that have been acquired in a single session 
(1),(2). This allows direct correlation of anatomical and functional information, 
increasing sensitivity and specificity whilst adding clarity to indeterminate 
cases (3). SPECT-CT offers an excellent example of hybrid imaging, 
combining the functional ability of single photon emission computed 
tomography (SPECT) with the anatomical ability of x-ray computed 
tomography (CT).  
 
In this article we discuss the concept of incidental findings on low-resolution 
CT images utilised in SPECT, with particular emphasis on myocardial 
perfusion imaging (MPI). 
 
The strength of SPECT lies in gaining pathophysiological detail in a minimally 
invasive way (4). Pathological processes can be identified by the uptake of 
radiopharmaceuticals but the precise location is often difficult to ascertain due 
to lack of anatomical landmarks and low image resolution.   Moreover, uptake 
on some scans is often non-specific, revealing abnormalities without specific 
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cause.  CT can provide a useful means of localisation, also enabling 
additional characterization by virtue of providing a site-specific 
correspondence between anatomical and physiological information.  
 
SPECT images are susceptible to artifact as a result of attenuation deficits 
due to scatter and absorption of photons (5),(6),(7). In order to improve image 
quantification and reduce attenuation artifacts, a low-dose CT acquisition can 
be performed allowing attenuation correction (AC) of the SPECT images.  CT 
attenuation correction (CTAC) is now commonly used because this often 
improves image quality and increases overall diagnostic accuracy (5). 
 
There are therefore three distinct reasons why CT may be combined with 
SPECT: 
1. CT can be used to characterise an abnormality seen on the SPECT 
images.  This will usually require a diagnostic quality (high resolution) 
CT scan.   
2. CT can be used for localisation of an abnormality seen on the SPECT 
images.   
3. CT can be used for AC of the SPECT images.  This only requires a low  
 
resolution CT acquisition, typically using a much lower ionising  
 
radiation dose than that required for diagnostic quality CT. Although the  
 
images are considered to be non-diagnostic, they often reveal  
 
incidental findings.   
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Incidental Findings 
 
An incidental finding can be defined as an unsuspected finding that is not 
related to the clinical reason for performing the diagnostic test (8),(9). Table 1 
summarises some typical examples of incidental findings that can be 
identified on CTAC images of the chest. 
 
Incidental findings may or may not already be known from previous diagnostic 
tests.  Findings that are already known to the clinician are likely to have a 
management strategy in place and so often do not require further 
investigation.  Previously unknown incidental findings are termed new 
incidental findings and are likely to fall into one of three categories: clinically 
significant, clinically insignificant or indeterminate.  Clinically significant 
incidental findings have a high suspicion of underlying pathology that could 
impact negatively on patient wellbeing, requiring further investigation (9).  
 
Table 1 – Examples of incidental findings on SPECT-CT images of the chest 
 
The frequency of incidental findings on CTAC images is particularly high 
within the thorax (10), possibly due to the inherent contrast resolution and low 
attenuation of the x-ray beam through this area.  Lung cancer shares co-
morbidities with heart disease; the clinical reason that these patients are 
being scanned.  It is, therefore, not surprising that extra-cardiac pathology is 
frequently detected.   
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The high number of incidental findings identified on CTAC images causes a 
dilemma.  The acquisition was intended for attenuation correction alone and 
not for evaluation, and the relatively low-resolution of the CTAC images 
means that characterization of findings is often not possible. Additionally, 
unlike diagnostic quality CT examinations of the chest and abdomen, there is 
likely to be breathing artifact on CTAC images because patients are not 
required to breath-hold. The cranio-caudal range of the CTAC acquisition is 
also limited to the cardiac area only; detection of incidental findings is 
therefore also restricted.  
 
Incidental findings on CTAC images from SPECT during myocardial 
perfusion imaging (MPI) 
 
The number of incidental findings on the CTAC images produced during 
SPECT MPI is noteworthy and the number of clinically significant and 
indeterminate findings can often be as high as 10% (10). 
 
A high proportion of findings on chest CT are pulmonary nodules (11).  Whilst 
the majority of lung nodules are benign, there is potential for them to develop 
into lung cancer (12).  CTAC images, which often reveal lung nodules as well 
as other pathologies, were never intended for radiological reporting but there 
is growing evidence to suggest that they should be (10). 
 
Lung cancer is the leading cause of death in most countries including the 
United States (12),(13).  Early lung cancer is often asymptomatic and 
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symptoms only arise when the disease is at an advanced stage; the prognosis 
for lung cancer is consequently poor (13).   However, the prognosis for non-
small cell lung cancer (NSCLC) improves significantly if it is detected at an 
early stage when surgical resection is possible (12),(13).  This is not the case 
with small cell lung cancer (SCLC).  Recommendations for the management 
of pulmonary nodules have been developed from lung cancer screening trials, 
suggesting a necessary balance between early intervention to reduce 
mortality from lung cancer, and the risks of early morbidity and mortality from 
intervention of false-positive findings and over diagnosis (11).  
 
The high prevalence of lung nodules on CT of the chest is of particular 
concern during SPECT-CT MPI because any such findings will be incidental 
and may signpost a patient to an alternative or additional care pathway. 
Although there is an argument for early treatment of lung cancer, the 
detection of lung nodules on CTAC images does not necessarily result in 
reduced mortality from lung cancer. A high proportion of lung nodules are 
ultimately found to be benign and the patient might not benefit, and might 
actually be harmed, from these being followed up. 
 
This sentiment is echoed by the outcomes of lung cancer screening trials; 
mortality must be reduced and the benefits to the patient must outweigh the 
risks for a screening programme to be effective (12).  The National Lung 
Screening Trial (NLST) has demonstrated that it is possible to reduce 
mortality from lung cancer by using low-dose CT screening in place of chest 
x-ray and sputum tests (14).  However, in doing so, there is a high rate of 
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false-positive findings and over diagnoses as well as an increased radiation 
burden to the patient (15).  Over diagnosis of indolent tumours that would not 
have become symptomatic in a patient’s lifetime have cost implications as 
well as raising patient anxiety and morbidity in the same way that false-
positive findings might (16).  Consequently, several organisations have made 
the decision not to implement screening programmes.  Where screening 
programmes have been implemented, they are focused specifically to the 
population at high risk (17). 
 
This adds to the dilemma of whether clinicians should review the CTAC 
images.  Reviewing them and providing a report could possibly enable early 
diagnosis of pathology and potentially a better prognosis.  However, 
identifying incidental findings could increase risk to the patient without 
necessarily providing any benefit. Further diagnostic examinations are often 
associated with an increase in ionising radiation dose and possibly invasive 
procedures that can carry physical risk and psychological harm to the patient 
(9),(18),(19).  Furthermore, only a very small percentage of these incidental 
findings are significant at definitive diagnosis (9),(20),(21).  
 
Exclusion of intravenous contrast use in CTAC  
 
There is often poor inherent contrast resolution between organs and soft 
tissues within the body due to relatively small differences in density. The use 
of contrast agents artificially improves contrast resolution between soft tissue 
structures. The iodination of the contrast agent increases the density within 
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the organs and so will affect the extent of attenuation of the x-ray beam that 
occurs.  The different organs take up contrast at different rates and this 
results in an increase in contrast resolution on the CT images. Similarly, 
pathological tissue can demonstrate selective uptake of contrast agents; 
tumours that are highly vascular tend to enhance avidly whereas ischaemic 
tissue tends not to enhance.  This improves demonstration of pathology in 
relation to normal tissue and aids characterisation of the pathology.  It is 
unusual to perform diagnostic CT of the chest, abdomen and pelvis without 
the use of intravenous contrast for this reason.  
 
The use of intravenous contrast with SPECT-CT is not without problems. 
Contrast agents will attenuate gamma rays in the same way that they 
attenuate x-rays.  The result is degradation of the quality of the SPECT 
images.  Contra-indications relating to the use of iodinated intravenous 
contrast agents also exist.   
 
CTAC images are not considered to be diagnostic because of the acquisition 
parameters used along with the lack of intravenous contrast to enhance 
contrast resolution. 
 
Image quality 
 
The image quality of CTAC images is directly related to how the images have 
been acquired, typically with a low tube current (mA) and a wide slice width. 
This enables attenuation correction to be performed with the production of co-
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incidental low-resolution CT images.  The long acquisition time results in 
motion artifact from breathing on the CTAC images. The nature of incidental 
findings can be difficult to determine, resulting in a high number of false-
positive findings.  
 
As technology has progressed, multi-detector CT (MDCT) scanners have 
been utilised in some hybrid systems.  MDCT offers increased technological 
capabilities with the potential to produce CT images of a superior quality than 
CTAC images typically associated with the earlier systems.  The potential to 
utilise narrow slices, reduce imaging time and utilise a higher mA has 
provided the option to improve image quality that, in some cases, is 
comparable to diagnostic CT.  This has inevitably led to a variation in CTAC 
image quality in different departments that is related not only to the capability 
of the CT scanner but also to the way in which parameters have been 
optimised (20). There are ethical considerations when CT image quality is 
improved in this way because there will be an inevitable increase in ionising 
radiation dose to the patient, for an uncertain gain.   
 
CT parameters relating to patient dose and image quality 
 
CT image quality is dependent upon how the data is acquired and also how it 
is reconstructed and viewed.  Ideally, we would choose the best image quality 
possible but this would involve changing the acquisition parameters in a way 
that would greatly increase the radiation dose to the patient.  Therefore, it is 
necessary to use a technique called optimisation, (22) the aim of which is to 
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produce the required image quality for the least radiation dose.  This does not 
necessarily mean the best image quality or the lowest radiation dose but is a 
compromise so that the images produced are tailored to the purpose for which 
they are acquired. 
 
Diagnostic CT results in images that are of sufficient quality that a diagnosis 
can be made.  It is usually necessary for images to have good spatial and 
contrast resolution and be free from artifacts.  This is not true for the CTAC 
acquisition for MPI.  The acquisition is merely for attenuation correction 
purposes and so the acquisition parameters can be significantly reduced.   
 
The mA used for CTAC is much lower than that used for diagnostic quality CT 
enabling the radiation dose to the patient to be reduced.  Resultant CT 
images will be noisy and have poor contrast resolution.  The slice width for 
CTAC is usually considerably wider than that of diagnostic CT.  This also has 
an effect on image quality and will reduce the spatial resolution (ability to 
determine fine detail) but it will improve contrast resolution. The long rotation 
time, frequently associated with some of the older SPECT-CT systems, 
results in a longer overall scan time.  This renders the CTAC images 
susceptible to motion artifact, especially within the thorax and abdomen.  
Whilst this has no significance for CTAC purposes, it does become relevant 
when the intent is to make a diagnosis from images.  
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Table 2 – Examples of how diagnostic CT Chest acquisition parameters might 
differ for CTAC MPI 
 
‘Diagnostic’ value of CTAC MPI images acquired with different image 
qualities 
 
Lesion detection performance studies, using the Free-response Receiver 
Operating Characteristic (FROC) method, have been conducted to investigate 
the influence of different CTAC image qualities on detection of nodules on 
chest phantoms.  FROC is a method to assess observer performance and 
captures the observer’s ability to say where the lesion is and assign a 
confidence rating to their decision. 
 
In a lung phantom study, variation of mA values (1, 1.5, 2 and 2.5) on one 
SPECT-CT system, with all other parameters remaining unchanged, had no 
statistically significant difference in performance in lesion detection at the 
different mA values (23). In a further lung phantom study involving a range of 
SPECT-CT systems there was a difference in lesion detectability relative to 
the capability of the CT unit (24). These results were reproduced in a study 
using the same chest phantom on two different SPECT-CT systems. Here, 
lesion detection was found to be more reliable on one system than the other 
and was related to the reconstruction algorithms used on one CT unit rather 
than the acquisition parameters (25).  It is worth noting that the phantom was 
stationary in all studies and so did not truly represent the clinical situation 
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where motion artifact from breathing would cause degradation of the CTAC 
images. 
 
A 2-year multi-centre study that took place in four nuclear medicine 
departments in the UK, was granted local approval from each participating 
hospital and ethical approval from the University of Salford, following advice 
from the Health Research Authority (26).  Positive findings were identified on 
the CTAC images of 962 (28%) of 3485 patients undergoing SPECT MPI.  Of 
these findings, 824 (24%) were new findings. Eighty-four (2.4%) patients had 
findings that were thought to be clinically significant at the time of the imaging 
and had not been known about previously, but only 10 (0.29%) patients had 
findings that were confirmed to be clinically significant at definitive diagnosis.  
In this study 74 out of 84 patients had false-positive findings that involved 
follow up diagnostic tests and possibly intervention before a definitive, 
negative outcome was reached.  This has the implication of increased 
physical and psychological risk to the patient and raises the question about 
whether the CTAC images should be reported.   
 
The positive predictive value (PPV) across all the centres was low and this 
finding resulted in one centre stopping reporting CTAC images.  Statistically 
there was no significant difference between the PPV for CTAC images 
acquired using low resolution and better resolution machines.  The study 
concluded that routine reporting of CTAC images was not beneficial.  The 
information from this study appears to be novel and no similar clinical studies 
were identified.   
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Whether to report CTAC images is a common dilemma as the detection of 
early pathology can lead to an improved prognosis. However, further 
investigations for characterisation can be costly and increase the radiation 
burden and other risks to the patient (27).  
 
Patient Perspective   
 
False-positive incidental findings or findings that result in an over diagnosis 
can lead to increased patient anxiety. Whilst malignancies diagnosed at an 
early stage might potentially result in reduced patient mortality, only a very 
small percentage of findings on CTAC images have been found to be 
malignant or detrimental to the patient at definitive diagnosis (28). 
 
The literature surrounding the psychological effects of patients who have 
incidental findings during SPECT-CT examinations is limited.  There is, 
however, an abundance of literature relating to the psychological effects of 
patients who have been recently diagnosed with cancer or who are awaiting 
definitive diagnosis, and some parallels can be drawn to patients with 
incidental findings.   
 
Patients who have incidental findings as part of a screening examination or 
are being investigated for a suspected cancer will usually have a care 
pathway and support structure in place.  Support structure typically involves 
nursing, medical and other professionals being available to help the patient 
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and their families. This is often not the case for patients who have incidental 
findings during SPECT-CT.  They will receive limited support due to the 
unexpected nature of the findings. 
                          
Pulmonary nodules are one of the most frequent incidental findings on CT of 
the thorax (29),(19). These can be single or multiple and can be of unknown 
significance.  Most nodules are benign but if they are indeterminate, they will 
require surveillance, which can take 2 to 3 years (30).  Almost all patients who 
are told that they have a pulmonary nodule assume that they have cancer 
(16).  Just raising the possibility of cancer can be threatening (17) and can 
lead to distress up until, and possibly beyond, definitive diagnosis (18). 
 
Pulmonary nodules are of particular clinical relevance(8), as they do have the 
potential to become malignant, although the majority will be benign (31). 
Further management of pulmonary nodules is based upon size, the likelihood 
of malignancy increasing with the size of the nodule (32),(33).  The 
indeterminate nature of pulmonary nodules frequently leads to follow up CT 
imaging over a period of time to monitor any change in size of the nodule.  If 
its size remains stable over a period of 2 years then it is considered to be 
benign.  This inevitably increases the radiation burden to the patient along 
with anxiety levels.  Biopsy of pulmonary nodules, which would give a more 
definitive answer, is often not possible due to their small size and location 
within the lung (32). Despite reassurance, the patient might believe that they 
have cancer in the absence of a definitive diagnosis.   
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Lung cancer screening involves harm as well as benefit and in some 
circumstances, the harm could outweigh the benefit (33).  This also applies to 
patients with incidental findings on CTAC images. The harms from over 
treatment of false-positive findings should be considered when considering 
the benefits of reviewing these images (34). Whilst patients may gain some 
reassurance from a negative screening examination, this cannot be applied to 
CTAC due to the limited range of the chest MPI imaging. Therefore, a normal 
CT MPI CTAC scan does not exclude pathology that falls outside this limited 
range. 
 
Early detection of lung cancer does not necessarily mean improved outcome.  
Approximately 25-30% of patients will present with potentially curable disease 
(35), but lung cancers develop quickly and metastasise early, often leading to 
a poor prognosis (19). Metastases are frequently present at the time of initial 
presentation.  This also needs to be balanced against the high rate of benign 
pathology that is also be detected (19). 
 
The psychological effects of patients who are diagnosed with false-positive 
findings can discourage patients from attending screening or diagnostic 
procedures in the future (33). If they have had a significant mis-diagnosis then 
they are likely to lose trust in diagnostic procedures.  Psychological effects 
can be transient or more persistent.  At initial diagnosis the patient is more 
likely to suffer anxiety but over time this tends to develop into depression.  
Both anxiety and depression can persist before and after treatment (35). 
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Financial and time implications when reporting CTAC findings 
 
The financial impact and time aspects need to be taken into consideration 
when routine reporting of CTAC images occurs.  A radiological report takes 
time to construct and in the case of clinically significant findings, is likely to 
affect future management of the patient.  This is justifiable when there is a net 
patient benefit.  However, this appears not to be the case when reporting 
CTAC images that demonstrate a high yield of false-positive findings.  
Similarly, follow up examinations that are performed to assist definitive 
diagnosis will inevitably have cost and time implications that will not 
necessarily benefit the patient and might, in fact, be a potential cause of 
patient harm (36). The cost-effective nature of reporting CTAC images is 
brought into question along with the benefit and harms related to the patient.  
 
Conclusion 
 
CTAC yields low-resolution images that are not considered to be diagnostic. 
Whilst they can demonstrate pathology and incidental findings are common, 
there is increased potential for pathology to be missed or wrongly diagnosed 
when compared to diagnostic quality CT images.  
 
Incidental findings can be numerous on SPECT-CT MPI AC images and, 
regardless of definitive diagnosis, they can cause psychological distress to the 
patient.  One study has called into question the practice of producing a routine 
report for CTAC images from SPECT-MPI studies (28).  If these images are 
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reported, this should be done with caution and possibly with the use of a rider 
in the written report stating that the images are low-resolution and not 
intended for diagnosis.  Careful consideration should be given to the potential 
impact that an abnormal report could have on the patient.   
 
If the CTAC images are reported, a support structure and appropriate 
educational advice similar to those found in screening programmes might help 
patients who have a clinically significant incidental finding to understand their 
diagnosis.  
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Table 1 – Examples of incidental findings on SPECT-CT images of the chest 
 
Incidental Finding 
 
Coronary vessel calcification 
Vascular anomalies 
Valve replacement 
Pacemaker 
Atelectasis 
Effusion 
Consolidation 
Lobar collapse 
Nodules 
Mass 
Pulmonary metastases 
Ground glass opacities 
Aortic aneurysm 
Source: Adapted from (Coward et al, 2014)  
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Table 2 – Examples of how diagnostic CT Chest acquisition parameters might 
differ for CTAC MPI 
 
Parameter Diagnostic Value CTAC MPI Value 
kV 120 120 
mA Automated 
(300-400 approx.) 
1.5-33 
Rotation Time (s) 0.33 1.5-30 
Effective mAs 100-130 
(dependent on 
automated mA) 
24-50 
Acquired slice  
thickness (mm) 
0.5-1 5-10 
Reconstructed  
slice thickness (mm) 
3 5-10 
Pitch 0.75-1 1-2 
 
 
 
 
